Stem Cell Educator Therapy in Diabetes

A phase 2 trial registered on ClinicalTrials.gov. The registry status is unknown. It plans to enroll 100 participants.

Also called NCT03390231

  • Study
  • In this atlas

Overview

Design
Interventional study; allocation not applicable; no masking; primary purpose treatment
Phase
Phase 2
Enrolled
  • 100 participants (planned count) (from the registry)
Sponsor
Registry
  • NCT NCT03390231
Started
(actual) (from the registry)
Primary completion
(anticipated) (from the registry)
Completion
(anticipated) (from the registry)
Countries
China (from the registry)
Registry status
  • Unknown status (from the registry)

Technical summary

Registry record NCT03390231. Allocation not applicable; no masking; primary purpose treatment. Start 2017-11-27 (actual); primary completion 2020-12-30 (anticipated). Results not posted.

The registry's words

Labels as the registry gives them, not rewritten.

Brief title
Stem Cell Educator Therapy in Diabetes
Condition
Diabetes Mellitus, Type 1
Condition
Diabetes Mellitus, Type 2
Intervention (Combination product)
Stem Cell Educator therapy
Lead sponsor
Throne Biotechnologies Inc. (class: industry)
Collaborator
Chinese PLA General Hospital (class: other)

Record details

Record id
cardio:ct-nct03390231
Content hash
e82d496bb6da85e6852b5b83219161f0470fc9d501156413b8198550c34791c6